See also this year's filing and all EDGAR filings for this company.
PDF Report 0001808158_2022_Repare_Therapeutics_Inc.pdf
Logs
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAndComprehensiveIncomeLoss'} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001808158')"} |
Graph
Absolute values for 0001808158, Repare Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 351,414,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,604,000 |
| 3 | remainder_Assets | 11,697,000 |
| 4 | LiabilitiesCurrent | 35,089,000 |
| 5 | LiabilitiesNoncurrent | 45,205,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 26,213,000 |
| 9 | ResearchAndDevelopmentExpense | 90,047,000 |
| 10 | remainder_Expenses | -1,678,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 7,674,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 368,715,000 |
| 1 | Liabilities | 80,294,000 |
| 2 | Expenses | 114,582,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 288,421,000 |
| 5 | NetIncome | -106,908,000 |
| 6 | ComprehensiveNetIncome | -106,908,000 |
| 7 | BaseVar | 285,632,500 |
| 8 | EconomicCapitalRatio | 1.73 |